Coherus Biosciences | CHRS - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
AbbVie USD 3.59B 28.65B 2025-12
Acadia Pharmaceuticals USD 12.25M 1.34M 2026-03
Akebia Therapeutics USD 8.39M 12.8M 2026-03
ALKERMES USD 102.36M 5.59M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Amarin USD 48.15M 2.8M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Baxter International USD 1.09B 87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Coherus Biosciences USD 9.91M 14.98M 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Fujifilm JPY 292.7B 15.36B 2026-03
Gilead Sciences USD 645M 70M 2026-03
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
Merck USD 3.86B 541M 2026-03
Myriad Genetics USD 32.6M 2.6M 2026-03
Pacira USD 14.01M 1.14M 2026-03
Perrigo USD 434.8M 39.7M 2026-03
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Teva Pharmaceutical Industries USD 2.6B 65M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Xencor USD 7.92M 2.91M 2026-03
Zoetis USD 507M 20M 2026-03